glomeruli, this spatial segregation is even more pronounced. Using super-resolution microscopy, Subramanian et al. show the INF2 N-fragment accumulates in foot processes, whereas the C-fragment remains in the cell body. Although FSGS-associated mutations did not affect proteolytic cleavage of INF2, an INF2 N-fragment bearing the FSGS-associated R218Q mutation had greatly reduced ability to accumulate at cell edges or in foot processes. Importantly, the authors also show the INF2(R218Q) N-fragment can dimerize with the wild-type N-fragment and prevent the wild type from being recruited to cell edges, providing a potential explanation for the dominant mode of inheritance of INF2-associated FSGS. Finally, pointing to possible significance for INF2 in other kidney diseases, the authors noted that INF2 N-fragment localization correlated with podocyte health in Alport syndrome and in lupus nephritis. That is, among glomeruli from patients with these conditions, the INF2 N-fragment was present in normal-appearing foot processes, but absent from regions exhibiting foot process effacement (FPE), while in all cases the C-fragment remained in the podocyte cell body. Based on these combined results, Subramanian and colleagues propose a model whereby, after cathepsin cleavage, the DIDcontaining INF2 N-fragment enters the foot processes to inhibit resident mDIA formins. Since the FH2-containing C-fragment is retained in the cell body through anchorage to the endoplasmic reticulum, the net effect is an inhibition of formin-mediated actin assembly in the foot processes. The correlation between INF2 N-fragment mislocalization and occurrence of FPE hints that disinhibitionofmDIA formins in absence of INF2-DIDmight play a role in FPE. Studies from zebrafish provide support for this, where knockdown of INF2 expression results in FSGS-like phenotypes that are reversed by knockdown of fish DIA2 formin.8 mDIA formins are frequently associated with the assembly of contractile actin filament structures, and cultured podocytes exhibit apparent increased mDIA-dependent contractility with loss of INF2 N-fragment function. Intriguingly, contractile actin structures are normally absent from podocyte foot processes, but have been noted to accumulate at the basal aspect of podocytes in a number of kidneydiseases, including FSGS.9Although it is unclear whether appearance of those contractile structures is cause or effect of FPE, the results presented here hint that, in INF2-dependent FSGS, increased contractility may be causative. Important remaining questions are the identity of binding partners for the INF2 N-fragment in glomeruli, and understanding of why the INF2 N-fragment becomes displaced from foot processes in other kidneydiseases. Thesefindings also have implications for other cell types, as cathepsin-mediated cleavage of INF2 also occurred in nonpodocyte HEK293T cells. Thus, these exciting results indicate that actin cytoskeletal regulation via this novel crosstalk between different formins may be a common mode of formin activity.
[1]
H. Higgs,et al.
FSGS-Causing INF2 Mutation Impairs Cleaved INF2 N-Fragment Functions in Podocytes.
,
2020,
Journal of the American Society of Nephrology : JASN.
[2]
R. Thadhani,et al.
Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study.
,
2019,
Journal of the American Society of Nephrology : JASN.
[3]
R. Naik,et al.
The current state of sickle-cell trait: implications for reproductive and genetic counseling.
,
2018,
Blood.
[4]
Jenny I. Shen,et al.
Kidney Disease Among African Americans: A Population Perspective.
,
2018,
American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5]
G. Fernández-Juárez,et al.
Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults
,
2018,
Clinical kidney journal.
[6]
R. Naik,et al.
The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait
,
2017,
Expert review of hematology.
[7]
A. Reiner,et al.
Sickle Cell Trait and the Risk of ESRD in Blacks.
,
2017,
Journal of the American Society of Nephrology : JASN.
[8]
R. Hebbel,et al.
Sickle cell disease: renal manifestations and mechanisms
,
2015,
Nature Reviews Nephrology.
[9]
C. Macrae,et al.
Human Kidney Disease-causing INF2 Mutations Perturb Rho/Dia Signaling in the Glomerulus
,
2014,
EBioMedicine.
[10]
M. Gladwin,et al.
Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia
,
2014,
British journal of haematology.
[11]
K. Devriendt,et al.
De novo INF2 mutations expand the genetic spectrum of hereditary neuropathy with glomerulopathy
,
2013,
Neurology.
[12]
D. Breitsprecher,et al.
Formins at a glance
,
2013,
Journal of Cell Science.
[13]
G. Mollet,et al.
INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.
,
2011,
The New England journal of medicine.
[14]
C. Langefeld,et al.
Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
,
2011,
Kidney international.
[15]
H. Higgs,et al.
Rho activation of mDia formins is modulated by an interaction with inverted formin 2 (INF2)
,
2011,
Proceedings of the National Academy of Sciences.
[16]
A. Kshirsagar,et al.
High prevalence of sickle cell trait in African Americans with ESRD.
,
2010,
Journal of the American Society of Nephrology : JASN.
[17]
L. Otterbein,et al.
Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.
,
2006,
The Journal of clinical investigation.
[18]
M. Gladwin,et al.
The Perfusion Paradox and Vascular Instability in Sickle Cell Disease
,
2004,
Microcirculation.